Results

eNauka >  Results >  Efficacy, Safety, and Tolerability of Efgartigimod in Acetylcholine Receptor Autoantibody Seronegative Patients with Generalized Myasthenia Gravis: Integrated Interim Analysis of the Adapt and Adapt plus Studies
Title: Efficacy, Safety, and Tolerability of Efgartigimod in Acetylcholine Receptor Autoantibody Seronegative Patients with Generalized Myasthenia Gravis: Integrated Interim Analysis of the Adapt and Adapt plus Studies
Authors: Howard, James F Jr; Bril, Vera; Tuan, Vu; Karam, Chafic; Perić, Stojan Z.  ; De Bleecker, Jan L.; Murai, Hiroyuki; Pasnoor, Mamatha; Sacca, Francesco; Meisel, Andreas;
Issue Date: 2022
Publication: Muscle & nerve (Abstracts from Myasthenia Gravis Foundation of America's 14th International Conference on Myasthenia Gravis and Related Disorders, May 10-12, 2022, Miami, Florida)
ISSN: 0148-639X Muscle and Nerve Search Idenfier
Publisher: Hoboken, NJ : John Wiley & Sons
Type: Conference Paper
Collation: vol. 65 br. Suppl 1 str. S13-S14
WoS-ID: 000813311100026
URI: https://enauka.gov.rs/handle/123456789/819317
URL: https://onlinelibrary.wiley.com/doi/epdf/10.1002/mus.27540
Metadata source: (Preuzeto iz Nasi u WoS)
M-category: 
Mp. category will be shown later

Find the DOI


Google ScholarTM

Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.